Fagron Fortifies Iberian Market Leadership with Guinama Acquisition

Fagron, the global leader in pharmaceutical compounding, has bolstered its position in the Iberian market with the acquisition of Guinama, a Spanish company specializing in repackaging and distribution of active pharmaceutical ingredients and excipients. This strategic move aligns perfectly with Fagron's disciplined approach to growth and solidifies its market leadership in the region.

Guinama, based in Valencia, Spain, is renowned for its excellent customer service and strong competitive position, particularly for high-volume and fast-moving products. By integrating Guinama's operations, Fagron strengthens its market positioning in the Iberian pharmaceutical compounding market and further cements its leading role within the sector and country.

The enterprise value of the acquisition is approximately €22 million, with Guinama generating low double-digit (€m) of annual revenue and an EBITDA margin slightly above Fagron's existing group margin. Rafael Padilla, CEO of Fagron, commented on the acquisition: "The acquisition of Guinama aligns perfectly with our disciplined, strategic approach to growth. This acquisition solidifies our repackaging and distribution activities in EMEA, whilst strengthening our market leadership position in Iberia. Key synergies of this integration will come from optimized sourcing, streamlined back-office operations, centralized warehousing, and a shift of production to Poland."



The acquisition of Guinama is expected to have a positive impact on Fagron's financial performance, particularly in terms of revenue growth and EBITDA margin improvement. Guinama's revenue will contribute to Fagron's overall revenue growth, while synergies from the integration, such as optimized sourcing and streamlined operations, should lead to improved operational efficiency and an increase in EBITDA margin.

In conclusion, Fagron's acquisition of Guinama is a strategic move that solidifies its market leadership position in the Iberian pharmaceutical compounding market and contributes to its global expansion strategy. By expanding its repackaging and distribution activities in EMEA and strengthening its market leadership in Iberia, Fagron continues to demonstrate its commitment to disciplined growth and long-term success.